IONIS PHARMACEUTICALS INC (IONS) stock: key figures, P/E, revenue and dividend

IONIS PHARMACEUTICALS INC financials

About IONIS PHARMACEUTICALS INC

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also provides QALSODY for the treatment of Amyotrophic Lateral Sclerosis (ALS); TEGSEDI for the treatment of ATTRv-PN in adults; and WAYLIVRA for treatment for FCS and familial partial lipodystrophy. It also develops products under Phase 3 clinical trials, such as Olezarsen for patients with hypertriglyceridemia (SHTG) and cardiovascular disease (CVD); and Zilganerse, a potential treatment for people with genetically confirmed Alexander disease, as well as ION582 which is in Phase 3 clinical trial for the potential treatment of AS, a rare genetic neurological disease. In addition, the company develops Eplontersen to degrade mutant and wild-type TTR mRNA through binding to the TTR mRNA; Pelacarsen to inhibit the production of apolipoprotein(a) in the liver to offer a direct approach for reducing lipoprotein(a); Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus; Sefaxersen to reduce the production of complement factor B and lower activation of the alternative complement pathway; and Ulefnersen to reduce the production of the fused in sarcoma, as well as other mid-stage pipeline investigational medicines. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with GSK, AstraZeneca, Novartis, and Roche, as well as with Metagenomi. The company was incorporated in 1989 and is headquartered in Carlsbad, California.

More stocks

• NEWMARKET CORP (NEU)
• Zurn Elkay Water Solutions Corp (ZWS)
• Gildan Activewear Inc. (GIL.TO)
• El Puerto de Liverpool S.A.B. de C.V (LIVEPOLC-1.MX)
• Asymchem Laboratories Tian Jin Co Ltd (002821.SZ)
• AXIS CAPITAL HOLDINGS LTD (AXS)
• Sejahteraraya Anugrahjaya Tbk (SRAJ.JK)
• South Bow Corp (SOBO.TO)
• Shenzhou International Group Holdings Ltd (2313.HK)
• Brother Industries Ltd (6448.T)
• Spirax Group PLC (SPX.L)
• H Lundbeck A/S (HLUN A.CO)